At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Apr 30, 2026 at 17:38 ET
Three C-suite insiders at Nurix Therapeutics (NRIX) sold a total of ~$184K in open-market shares over a 7-day window, a trivial amount relative to the $1.7B market cap. Non-cash derivative exercises accompanied the sales but carry no economic signal. The insider activity is routine and does not indicate any material change in outlook.
- Total open-market sales of ~$184K by CFO, CLO, and CSO
- Sales represent ~0.011% of $1.7B market cap
- Non-cash derivative exercises (options) also filed, but $0 value
- No other recent material filings or catalysts identified
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access